CTOs on the Move

Bioanalytical Systems

www.basinc.com

 
BASi is a drug discovery and development services company with the energy and expertise to help you with your drug development project. We provide world-class research to the global pharmaceutical industry. Our services include Preclinical Toxicology, Early In Vivo PK, Bioanalysis and a full range of pharmaceutical analysis services. BASi also manufactures innovative scientific instruments including the Culex® Automated In Vivo Sampling System which can collect blood, bile, microdialysates, activity behavior, telemetry data and more from awake, freely-moving subjects. We are known for our scientific expertise, responsiveness to clients, exemplary regulatory record, and helping our clients meet key milestones on ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.basinc.com
  • 2701 Kent Ave
    West Lafayette, IN USA 47906
  • Phone: 765.463.4527

Executives

Name Title Contact Details

Similar Companies

Cook Children's Medical Center - Cook Children's Community Clinics

Cook Children's Medical Center - Cook Children's Community Clinics is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Healthcare Management Partners

Healthcare Management Partners, LLC is a hospital and healthcare services management firm. HMP is a firm led by a team of C-Level healthcare executives that quickly define and solve problems to produce exceptional results for healthcare organizations and their stakeholders. With its extensive experience, Financial Modeling and Data Analysis Tools and action-based business model, HMP provides senior executive led management, financial advisory and litigation support services to hospitals and other healthcare organizations and their creditors, investors and business partners. The complex and ever-changing nature of the healthcare markets can test even the strongest organizations. Healthcare Management Partners serves as advisor to hospitals and other healthcare providers facing strategic decisions directly impacting current or future financial performance. HMP also frequently serves banks, bond holders, private equity firms or committees of unsecured creditors and their legal and accounting advisors in conjunction with complex business transactions or restructurings involving healthcare providers. We provide creditor advisory and operational and financial due diligence. Unlike many of our competitors, every financial advisory services engagement is led on the ground by experienced C-Level healthcare executives.

Reckitt Benckiser

We protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. Our products reach millions of people every day, as we fight to improve global access to the highest quality hygiene, wellness and nourishment. We`re a growing community of 40,000+ diverse, talented entrepreneurs, and the driving force behind some of the world`s most loved and trusted brands. Our portfolio includes household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Lysol, Dettol, Harpic, Cillit Bang, Finish and Vanish. Hygiene, Health and Nutrition are the focus areas of our business, and the categories under which our brands are organised. Each area is dedicated to building sustainable solutions that will help us address the challenges presented by global mega-trends like urbanisation, climate change and digital transformation. These global pressures are challenging public health systems and increasing the need for improved hygiene products, services and education. We continuously innovate in areas like personalised nutrition, wellness, and digital health and hygiene so that individuals, families and communities can live cleaner, healthier lives.

BioSig Technologies

BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.